Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nabiximols for spasticity in Multiple Sclerosis
NCT04657666Phase 3Completed
- Sponsor
- Jazz Pharmaceuticals plc
- Start
- Dec 2020
- Primary completion
- May 2022
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of cannabis extract in spasticity, sponsored by Jazz Pharmaceuticals plc. Started Dec 2020; status: completed.
02
Drugs
cannabis extract
03
Conditions
spasticity
Beyond the preview
Go deeper on NCT04657666.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04657666.